| 产品名称 |
点击数 |
| Anti-Human CD152/CTLA4 Recombinant Antibody |抗人CD152/CTLA4重组抗体(靶标：人细胞毒性T淋巴细胞相关蛋白4/CD152) |
419 |
| Anti-Bet v 1/Allergen Bet v I-A Recombinant Nanobody |抗Bet v 1/过敏原Bet v I-A纳米抗体(靶标：欧洲白桦花粉过敏原Bet v 1) |
593 |
| Research Grade Efbemalenograstim Alfa|研究级Efbemalenograstim Alfa(靶标：Efbemalenograstim Alfa(研究用)) |
591 |
| Anti-Human ANXA2 Recombinant Antibody |抗人ANXA2重组抗体(靶标：人膜联蛋白A2) |
339 |
| Human IgG1 (L234A/L235A/P329S), kappa Recombinant Isotype Control Antibody|人IgG1(L234A/L235A/P329S),κ型重组同型对照抗体(靶标：人免疫球蛋白G1(L234A/L235A/P329S突变体),κ轻链型同 |
688 |
| Anti-HPV16 L1/Major capsid protein L1 Recombinant Antibody |抗HPV16 L1/主要衣壳蛋白L1重组抗体(靶标：人乳头瘤病毒16型主要衣壳蛋白L1) |
375 |
| Anti-HPV16 L1/Major capsid protein L1 Recombinant Antibody |抗HPV16 L1/主要衣壳蛋白L1重组抗体(靶标：人乳头瘤病毒16型主要衣壳蛋白L1) |
454 |
| Anti-HPIV-3 Fusion glycoprotein F0 Recombinant Antibody |抗HPIV-3融合糖蛋白F0重组抗体(靶标：人副流感病毒3型融合糖蛋白F0) |
284 |
| Anti-HPIV-1 Fusion glycoprotein F0 Recombinant Antibody |抗HPIV-1融合糖蛋白F0重组抗体(靶标：人副流感病毒1型融合糖蛋白F0) |
579 |
| Anti-HPIV Fusion glycoprotein F0 Recombinant Antibody |抗HPIV融合糖蛋白F0重组抗体(靶标：人副流感病毒融合糖蛋白F0) |
503 |
| Anti-HPIV-3 Fusion glycoprotein F0 Recombinant Antibody|抗HPIV-3融合糖蛋白F0重组抗体(靶标：人副流感病毒3型融合糖蛋白F0) |
391 |
| Human IgG1 (D356E/L358M), kappa Recombinant Isotype Control Antibody|人IgG1(D356E/L358M),κ型重组同型对照抗体(靶标：人免疫球蛋白G1(D356E/L358M突变体),κ轻链型同型对照) |
620 |
| Anti-Streptococcus suis Enolase Polyclonal Antibody|抗猪链球菌烯醇化酶多克隆抗体(靶标：猪链球菌烯醇化酶) |
427 |
| Anti-Human MYH2 Polyclonal Antibody|抗人MYH2多克隆抗体(靶标：人肌球蛋白重链2/快肌Ⅱa型) |
343 |
| Anti-CDV Phosphoprotein/P Polyclonal Antibody|抗CDV磷蛋白/P多克隆抗体(靶标：犬瘟热病毒磷蛋白) |
488 |
| Anti-CDV Matrix protein/M Polyclonal Antibody|抗CDV基质蛋白/M多克隆抗体(靶标：犬瘟热病毒基质蛋白) |
466 |
| Anti-CDV H/Hemagglutinin glycoprotein Polyclonal Antibody|抗CDV H/血凝素糖蛋白多克隆抗体(靶标：犬瘟热病毒血凝素糖蛋白) |
338 |
| Anti-CDV Protein C Polyclonal Antibody|抗CDV蛋白C多克隆抗体(靶标：犬瘟热病毒C蛋白) |
485 |
| Anti-VHH Recombinant Antibody , HRP|抗VHH重组抗体, HRP标记(靶标：重链抗体可变区/纳米抗体(HRP标记)) |
349 |
| Anti-VHH Recombinant Antibody , HRP|抗VHH重组抗体, HRP标记(靶标：重链抗体可变区/纳米抗体(HRP标记)) |
479 |
